C1ORF9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.03259680992596E-11 |
Normal-vs-Stage2 |
1.405900E-04 |
Normal-vs-Stage3 |
6.14900352857717E-11 |
Normal-vs-Stage4 |
7.94939669646055E-11 |
Stage1-vs-Stage2 |
2.950000E-01 |
Stage1-vs-Stage3 |
4.716400E-01 |
Stage1-vs-Stage4 |
4.240000E-01 |
Stage2-vs-Stage3 |
1.462030E-01 |
Stage2-vs-Stage4 |
1.666760E-01 |
Stage3-vs-Stage4 |
9.606800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63036251166204E-12 |
Normal-vs-AfricanAmerican |
2.20790052907205E-10 |
Normal-vs-Asian |
3.333900E-02 |
Caucasian-vs-AfricanAmerican |
4.765200E-01 |
Caucasian-vs-Asian |
6.694000E-01 |
AfricanAmerican-vs-Asian |
3.954800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.00710584105946E-14 |
Normal-vs-Female |
1.52090007254913E-10 |
Male-vs-Female |
7.731600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.559630E-04 |
Normal-vs-Age(41-60Yrs) |
2.62678767626312E-12 |
Normal-vs-Age(61-80Yrs) |
1.63613567139009E-12 |
Normal-vs-Age(81-100Yrs) |
8.28980000000534E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.268800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.272800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.843800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.716600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.242200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.847400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.004000E-03 |
Normal-vs-Grade 2 |
5.37014877011188E-13 |
Normal-vs-Grade 3 |
2.30448993221444E-12 |
Normal-vs-Grade 4 |
2.12859999626502E-08 |
Grade 1-vs-Grade 2 |
9.720200E-01 |
Grade 1-vs-Grade 3 |
5.185000E-01 |
Grade 1-vs-Grade 4 |
9.607200E-01 |
Grade 2-vs-Grade 3 |
1.052370E-01 |
Grade 2-vs-Grade 4 |
9.707400E-01 |
Grade 3-vs-Grade 4 |
2.544000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.13179490621474E-11 |
Normal-vs-ccB subtype |
1.84190000029893E-07 |
ccA subtype-vs-ccB subtype |
4.485900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.79531994510307E-12 |
Normal-vs-N1 |
5.942700E-03 |
N0-vs-N1 |
6.848400E-01 |
|
|